Moderna Inc (MRNA)
39.39
-0.17
(-0.43%)
USD |
NASDAQ |
Dec 20, 16:00
39.54
+0.15
(+0.38%)
Pre-Market: 20:00
Moderna Profit Margin (Quarterly): 0.70% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Merck & Co Inc | 18.95% |
| Pfizer Inc | 25.22% |
| Novavax Inc | -143.5% |
| Biogen Inc | 15.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -17.44% |
| Return on Assets | -12.92% |
| Return on Invested Capital | -17.44% |
| Gross Profit Margin (Quarterly) | 72.29% |
| Operating Margin (Quarterly) | -3.77% |
| Return on Net Operating Assets | -45.55% |